278
Views
2
CrossRef citations to date
0
Altmetric
Neurology: Original article

The impact of shift duration on the efficacy and tolerability of armodafinil in patients with excessive sleepiness associated with shift work disorder

, &
Pages 945-951 | Accepted 27 Dec 2013, Published online: 04 Feb 2014

References

  • McMenamin TM. A time to work: recent trends in shift work and flexible schedules. Mon Labor Rev 2007;130:3-15
  • Drake CL, Roehrs T, Richardson G, et al. Shift work sleep disorder: prevalence and consequences beyond that of symptomatic day workers. Sleep 2004;27:1453-62
  • American Academy of Sleep Medicine. Circadian rhythm sleep disorder, shift work type. In: Sateia MJ, ed. International Classification of Sleep Disorders: Diagnostic and Coding Manual. Westchester, IL: American Academy of Sleep Medicine, 2005:131-3
  • American Psychiatric Association. Sleep disorders. In: First MB, ed. Diagnostic and Statistical Manual of Mental Disorders: DM-IV-TR. Washington, DC: American Psychiatric Association, 2000:597-607
  • Swanson LM, Arnedt JT, Rosekind MR, et al. Sleep disorders and work performance: findings from the 2008 National Sleep Foundation Sleep in America poll. J Sleep Res 2011;20:487-94
  • Darwish M, Kirby M, D'Andrea DM, et al. Pharmacokinetics of armodafinil and modafinil after single and multiple doses in patients with excessive sleepiness associated with treated obstructive sleep apnea: a randomized, open-label, crossover study. Clin Ther 2010;32:2074-87
  • Darwish M, Kirby M, Hellriegel ET, et al. Pharmacokinetic profile of armodafinil in healthy subjects: pooled analysis of data from three randomized studies. Clin Drug Invest 2009;29:87-100
  • Czeisler CA, Walsh JK, Wesnes KA, et al. Armodafinil for treatment of excessive sleepiness associated with shift work disorder: a randomized controlled study. Mayo Clin Proc 2009;84:958-72
  • Erman MK, Seiden DJ, Yang R, et al. Efficacy and tolerability of armodafinil: effect on clinical condition late in the shift and overall functioning of patients with excessive sleepiness associated with shift work disorder. J Occup Environ Med 2011;53:1460-5
  • Erman MK, Yang R, Seidan DJ. The effect of armodafinil on patient-reported functioning and quality of life in patients with excessive sleepiness associated with shift work disorder: a randomized, double-blind, placebo-controlled trial. Prim Care Companion CNS Disord 2012;14. doi: 10.4088/PCC.12m01345
  • Son M, Kong JO, Koh SB, et al. Effects of long working hours and the night shift on severe sleepiness among workers with 12-hour shift systems for 5 to 7 consecutive days in the automobile factories of Korea. J Sleep Res 2008;17:385-94
  • Harma M, Sallinen M, Ranta R, et al. The effect of an irregular shift system on sleepiness at work in train drivers and railway traffic controllers. J Sleep Res 2002;11:141-51
  • Ayas NT, Barger LK, Cade BE, et al. Extended work duration and the risk of self-reported percutaneous injuries in interns. JAMA 2006;296:1055-62
  • Dembe AE, Erickson JB, Delbos RG, et al. The impact of overtime and long work hours on occupational injuries and illnesses: new evidence from the United States. Occup Environ Med 2005;62:588-97
  • Lombardi DA, Folkard S, Willetts JL, Smith GS. Daily sleep, weekly working hours, and risk of work-related injury: US National Health Interview Survey (2004–2008). Chronobiol Int 2010;27:1013-30
  • Akerstedt T, Peters B, Anund A, et al. Impaired alertness and performance driving home from the night shift: a driving simulator study. J Sleep Res 2005;14:17-20
  • Barger LK, Cade BE, Ayas NT, et al. Extended work shifts and the risk of motor vehicle crashes among interns. N Engl J Med 2005;352:125-34
  • Guy W. 028 CGI clinical global impressions. ECDEU Assessment Manual for Psychopharmacology Revised, 1976. DHEW Publication No. 1976:217-22
  • Kaida K, Takahashi M, Akerstedt T, et al. Validation of the Karolinska sleepiness scale against performance and EEG variables. Clin Neurophysiol 2006;117:1574-81
  • American Psychiatric Association. Global Assessment of Functioning (GAF) scale. In: First MB, ed. Diagnostic and Statistical Manual of Mental Disorders: DSM-IV-TR. Washington, DC: American Psychiatric Association, 2000:34
  • Sheehan DV. Sheehan disability scale. In: Rush AJ, First MB, Blacker D, eds. Handbook of Psychiatric Measures. Washington, DC: American Psychiatric Publishing Inc., 2008:100-2
  • Culpepper L. The social and economic burden of shift-work disorder. J Fam Pract 2010;59(1 Suppl):S3-11
  • Dinges DF, Arora S, Darwish M, et al. Pharmacodynamic effects on alertness of single doses of armodafinil in healthy subjects during a nocturnal period of acute sleep loss. Curr Med Res Opin 2006;22:159-67
  • Darwish M, Bond M, Ezzet F. Armodafinil and modafinil in patients with excessive sleepiness associated with shift work disorder: a pharmacokinetic/pharmacodynamic model for predicting and comparing their concentration–effect relationships. J Clin Pharmacol 2012;52:1328-42
  • United States Department of Labor. Bureau of Labor Statistics labor force statistics from the current population survey. Washington, DC: Bureau of Labor Statistics, 2012
  • Hanecke K, Tiedemann S, Nachreiner F, et al. Accident risk as a function of hour at work and time of day as determined from accident data and exposure models for the German working population. Scand J Work Environ Health 1998;24(Suppl 3):43-8
  • Folkard S, Tucker P. Shift work, safety and productivity. Occup Med (London) 2003;53:95-101
  • Black JE, Hull SG, Tiller J, et al. The long-term tolerability and efficacy of armodafinil in patients with excessive sleepiness associated with treated obstructive sleep apnea, shift work disorder, or narcolepsy: an open-label extension study. J Clin Sleep Med 2010;6:458-66
  • Schwartz JR, Khan A, McCall WV, et al. Tolerability and efficacy of armodafinil in naive patients with excessive sleepiness associated with obstructive sleep apnea, shift work disorder, or narcolepsy: a 12-month, open-label, flexible-dose study with an extension period. J Clin Sleep Med 2010;6:450-7

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.